105 related articles for article (PubMed ID: 6283344)
1. Inhibition of the in vitro growth of Plasmodium falciparum by D vitamins and vitamin D-3 derivatives.
Vial HJ; Thuet MJ; Philippot JR
Mol Biochem Parasitol; 1982 Mar; 5(3):189-98. PubMed ID: 6283344
[TBL] [Abstract][Full Text] [Related]
2. The biological activity of 25-hydroxycholecalciferol and 1,25--dihydroxycholecalciferol for rainbow trout (Salmo gairdneri).
Barnett BJ; Jones G; Cho CY; Slinger SJ
J Nutr; 1982 Nov; 112(11):2020-6. PubMed ID: 6290625
[TBL] [Abstract][Full Text] [Related]
3. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
Fisk CM; Theobald HE; Sanders TA
J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.
Kasinathan RS; Föller M; Koka S; Huber SM; Lang F
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):255-64. PubMed ID: 17180616
[TBL] [Abstract][Full Text] [Related]
5. Effect of dietary contents of cholecalciferol, 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on blood concentrations of 25-hydroxycholecalciferol, 1 alpha,25-dihydroxycholecalciferol, total calcium and eggshell quality.
Tsang CP; Grunder AA
Br Poult Sci; 1993 Dec; 34(5):1021-7. PubMed ID: 8156418
[TBL] [Abstract][Full Text] [Related]
6. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte.
Brand VB; Sandu CD; Duranton C; Tanneur V; Lang KS; Huber SM; Lang F
Cell Physiol Biochem; 2003; 13(6):347-56. PubMed ID: 14631141
[TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes.
Grellier P; Valentin A; Millerioux V; Schrevel J; Rigomier D
Antimicrob Agents Chemother; 1994 May; 38(5):1144-8. PubMed ID: 8067753
[TBL] [Abstract][Full Text] [Related]
8. Effects of Ca++ depletion on the asexual cell cycle of Plasmodium falciparum.
Wasserman M; Alarcón C; Mendoza PM
Am J Trop Med Hyg; 1982 Jul; 31(4):711-7. PubMed ID: 6808848
[TBL] [Abstract][Full Text] [Related]
9. D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol.
Kubodera N
Mini Rev Med Chem; 2009 Oct; 9(12):1416-22. PubMed ID: 19929815
[TBL] [Abstract][Full Text] [Related]
10. Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells.
Civitelli R; Kim YS; Gunsten SL; Fujimori A; Huskey M; Avioli LV; Hruska KA
Endocrinology; 1990 Nov; 127(5):2253-62. PubMed ID: 2226314
[TBL] [Abstract][Full Text] [Related]
11. Role of calmodulin in Plasmodium falciparum: implications for erythrocyte invasion by the merozoite.
Matsumoto Y; Perry G; Scheibel LW; Aikawa M
Eur J Cell Biol; 1987 Dec; 45(1):36-43. PubMed ID: 3127214
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor reduces Plasmodium falciparum growth and activates calcium signaling in human malaria parasites.
Cruz LN; Wu Y; Ulrich H; Craig AG; Garcia CR
Biochim Biophys Acta; 2016 Jul; 1860(7):1489-97. PubMed ID: 27080559
[TBL] [Abstract][Full Text] [Related]
13. Stage-dependent effects of analogs of gramicidin A on the growth of Plasmodium falciparum in vitro.
Otten-Kuipers MA; Roelofsen B; Op den Kamp JA
Parasitol Res; 1995; 81(1):26-31. PubMed ID: 7536920
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of growth inhibition of intraerythrocytic stages of Plasmodium falciparum by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).
Bulusu V; Thakur SS; Venkatachala R; Balaram H
Mol Biochem Parasitol; 2011 May; 177(1):1-11. PubMed ID: 21251933
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan-N-formylated gramicidin causes growth inhibition of Plasmodium falciparum by inducing potassium efflux from infected erythrocytes.
Otten-Kuipers MA; Coppens-Burkunk GW; Kronenburg NA; Vis Mde A; Roelofsen B; Op den Kamp JA
Parasitol Res; 1997; 83(2):185-92. PubMed ID: 9039702
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of serum 25-hydroxycholecalciferol in humans after administration of vitamin D and 25-OHD3].
Coen G; Taccone Gallucci M; Bianchini G; Lucentini G; Gallucci G; Bianchi AR; Matteucci MC; Picca S; Casciani CU
Boll Soc Ital Biol Sper; 1979 Oct; 55(20):2051-6. PubMed ID: 232847
[TBL] [Abstract][Full Text] [Related]
17. Requirements for maximal enrichment of viable intraerythrocytic Plasmodium falciparum rings by saponin hemolysis.
Orjih AU
Exp Biol Med (Maywood); 2008 Nov; 233(11):1359-67. PubMed ID: 18791132
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intraerythrocytic development of Plasmodium falciparum by proteinase inhibitors.
Rockett KA; Playfair JH; Ashall F; Targett GA; Angliker H; Shaw E
FEBS Lett; 1990 Jan; 259(2):257-9. PubMed ID: 2403526
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium citrate based anticoagulants on the growth activity of malaria parasites.
Liu ZX; Wang XF; Li SM; Li X; Xue CF; Miao J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec; 22(6):344-8. PubMed ID: 15830859
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: recrudescence of parasites in culture.
Nakazawa S; Kanbara H; Aikawa M
Exp Parasitol; 1995 Dec; 81(4):556-63. PubMed ID: 8542997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
